RxDoctor Payments Data
★ My doctorsLook up a doctor →

Jonathan Zager, MD

Surgical Oncology · Tampa, FLNPI 1629080304

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 35.8% of the total. Reporting peaked in 2020 at $64,360 and has fallen 89.8% since, to $6,589 in 2025. Among surgical oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$190,639in general payments, 2019–2025

Across 184 payments — averaging $1036.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$68K
  • Merck$22K
  • Menarini Silicon Biosystems, Inc.$20K
  • Array Biopharma Inc$18K
  • Sanofi$18K
  • Pfizer$16K
  • plus $29K from 18 others
$7,126in research payments, 2019–2025

Across 4 payments — averaging $1781.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$5K
  • Delcath Systems$2K

What the payments were for

  • Consulting fees$60,50232%
  • Speaking & faculty fees$102,45454%
  • Travel & lodging$22,75112%
  • Food & beverage$4,9323%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sun Pharmaceutical Industries Inc.75$68,334
Merck19$22,402
Menarini Silicon Biosystems, Inc.2$19,724
Array Biopharma Inc18$18,130
Sanofi13$17,503
Pfizer4$15,600
Merit Medical Systems Inc9$10,317
Baxter Healthcare11$5,736
Novartis3$4,368
Delcath Systems11$3,967
Amgen3$1,100
Alkermes, Inc.1$975
Immunocore Limited2$820
Dr.reddy's Laboratories,inc.1$420
E.r. Squibb & Sons, L.L.C.2$253
Regeneron Healthcare Solutions, Inc.2$243
DUSA Pharmaceuticals, Inc.1$156
Vector Surgical, LLC1$150
Genentech USA, Inc.1$139
Springworks Therapeutics, Inc.1$109
Secura Bio, Inc.1$70
Musculoskeletal Transplant Foundation Inc.1$52
Intuitive Surgical1$40
Ossio Inc1$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$190,639 in reported general payments places this provider in the 95th percentile of 133 surgical oncology providers in Florida.

See all surgical oncology providers in Florida →

Medicare billing

Part B allowed, 2024
$129,956
Medicare patients
156
Services billed
436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl29$65

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →